Technical Analysis for OPTN - OptiNose, Inc.

Grade Last Price % Change Price Change
grade C 9.19 -2.96% -0.28
OPTN closed down 2.96 percent on Friday, March 22, 2019, on approximately normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Up Up
See historical OPTN trend table...

Date Alert Name Type % Chg
Mar 22 Overbought Stochastic Strength 0.00%
Mar 21 Pocket Pivot Bullish Swing Setup -2.96%
Mar 21 Upper Bollinger Band Walk Strength -2.96%
Mar 21 Wide Bands Range Expansion -2.96%
Mar 21 Overbought Stochastic Strength -2.96%
Mar 21 Up 3 Days in a Row Strength -2.96%
Mar 21 Up 4 Days in a Row Strength -2.96%
Mar 21 Up 5 Days in a Row Strength -2.96%
Mar 21 Upper Bollinger Band Touch Strength -2.96%
Mar 20 Doji - Bearish? Reversal -2.34%

Older signals for OPTN ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
OptiNose, Inc. is a pharmaceutical company. The Company is focused on the development and commercialization of products for patients treated by ear, nose and throat, or ENT, and allergy specialists. The Company’s products candidates include XHANCE (Nasal Polyps), XHANCE (Chornic Sinusitis) OPN-300, OPN-021, and other. The Company’s lead product, XHANCE (fluticasone propionate) nasal spray, utilizes breath powered exhalation delivery system (EDS), to deliver a topically acting and potent anti-inflammatory corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps. XHANCE has a differentiated clinical profile with the potential to become part of the standard of care for this disease because it is able to deliver medication to the primary site of inflammation
Medicine Pharmaceutical Clinical Medicine Disease Organ Systems Inflammation Respiratory Therapy Allergy Glucocorticoids Sinusitis
Is OPTN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 30.0
52 Week Low 5.66
Average Volume 148,784
200-Day Moving Average 13.3116
50-Day Moving Average 7.5826
20-Day Moving Average 8.542
10-Day Moving Average 9.057
Average True Range 0.5726
ADX 28.74
+DI 25.7685
-DI 11.3723
Chandelier Exit (Long, 3 ATRs ) 8.142199999999999
Chandelier Exit (Short, 3 ATRs ) 8.4878
Upper Bollinger Band 9.7928
Lower Bollinger Band 7.2912
Percent B (%b) 0.76
BandWidth 29.285882
MACD Line 0.5212
MACD Signal Line 0.4682
MACD Histogram 0.053
Fundamentals Value
Market Cap 347.02 Million
Num Shares 37.8 Million
EPS -19.61
Price-to-Earnings (P/E) Ratio -0.47
Price-to-Sales 0.00
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 10.12
Resistance 3 (R3) 10.16 9.90 9.97
Resistance 2 (R2) 9.90 9.66 9.88 9.91
Resistance 1 (R1) 9.54 9.51 9.41 9.50 9.86
Pivot Point 9.28 9.28 9.21 9.26 9.28
Support 1 (S1) 8.92 9.04 8.79 8.88 8.52
Support 2 (S2) 8.66 8.89 8.64 8.47
Support 3 (S3) 8.30 8.66 8.42
Support 4 (S4) 8.26